Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized versus individualized growth hormone treatment in short children born small for gestational age
NL-OMON39333Phase 4Withdrawn
- Sponsor
- Dutch Growth Research Foundation
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin in Short stature in children born small for gestational age (2 arms), sponsored by Dutch Growth Research Foundation. Primary endpoints: Adult height, First-year growth response and 3 more. Planned start Aug 2012; status: withdrawn.
02
Drugs
somatropin
03
Conditions
Short stature in children born small for gestational age
Beyond the preview
Go deeper on NL-OMON39333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39333.